L ymphatic vessels have essential roles in maintaining the homeostasis of interstitial body fluid and facilitating immune responses in vertebrates. [1] [2] [3] In addition, lymphatic vessels have been associated with progression of diverse diseases in humans, including tumor metastasis and obesity. 4, 5 Malformation or obstruction of lymphatic vessels cause an accumulation of interstitial fluid resulting in the swelling of extremities, pathological conditions collectively categorized as lymphedema, which affect >140 million people worldwide. [6] [7] [8] [9] During development, lymphatic endothelial cells (LECs), the main component of lymphatic vessels, first appear around E10 in mice, embryonic week 6 to 7 in humans, and 3 days postfertilization (dpf) in zebrafish. [10] [11] [12] [13] Lineage tracing and in vivo time lapse analyses in mouse and zebrafish support the model proposed by Florence Sabin that the LECs may originate from ECs in the cardinal vein. 12, 14, 15 
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Apelin and its receptor Aplnr/Apj regulate a wide range of developmental and physiological processes. [16] [17] [18] [19] Although Apelin is widely expressed during development, the expression of Aplnr/Apj is more restricted. 16 In mouse, Apj is strongly expressed within the cardiovascular system as early as E8.0. 20 Similarly, aplnra and b are specifically expressed in developing ECs and cardiomyocytes in zebrafish. 17, 19 Consistent with the expression pattern, Apj knockout mice display various cardiovascular defects and are embryonic lethal in certain genetic background. [20] [21] [22] Zebrafish have 2 Apelin receptors, aplnra and aplnrb. 17, 19 Although aplnra and b are broadly expressed in areas including heart primordial cells and lateral plate mesoderm during early development, their expression gradually become restricted to blood vessel in late development. 19, 23 After 24 hours postfertilization, only venous ECs in the trunk region express detectable levels of aplnra, 23 suggesting that Apelin signaling may be essential for blood ECs (BECs) and LECs. Mutations in aplnrb cause similar developmental defects in zebrafish. 17, 19 Despite its proposed role in cardiovascular development, current analyses on Apelin signaling predominantly aim to address its role in vascular physiology, 16, [24] [25] [26] and consequently, the function of Apelin signaling in the development of lymphatic vessels remains largely unknown.
In this report, we examined the function of Apelin signaling in developing LECs and found that Apelin signaling provides a nonredundant function to induce serine-threonine kinase Akt/protein kinase B (AKT) activation, therefore serving as an essential signaling input to promote lymphatic development. Abrogation of Apelin signaling caused severe defects of the lymphatic structure in zebrafish embryos by substantially decreasing the phosphorylation of AKT1/2, independent of vascular endothelial growth factor-C (VEGF-C) signaling. Our data presented here support the idea that Apelin signaling is essential for proper lymphatic development.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Apelin Signaling Modulates the Proper Lymphatic Vessel Formation During Zebrafish Development
To delineate the roles of Apelin signaling in vascular development of zebrafish, we first attenuated the level of Aplnra by morpholino-mediated knockdown of aplnra (Figure IA-ID in the online-only Data Supplement). Because proper circulation is essential for lymphatic development, a suboptimal dose of aplnra morpholino was injected (1.8 ng/embryo) to avoid the early cardiac abnormalities that have been previously reported 17, 19 and assess the role of Apelin signaling specifically in lymphatic development ( Figure ID in the online-only Data Supplement). The general morphology and the rate of heartbeat at 4 dpf in embryos injected with 1.8 ng of aplnra morpholino were comparable with those of control morpholino-injected embryos ( Figure 1A and Figure IB and IC in the online-only Data Supplement). In addition, patterning of intersegmental vessels (ISVs), the dorsal aorta, and the cardinal vein was not affected in 4 dpf embryos injected with 1.8 ng of aplnra morpholino ( Figure 1A ).
Although the vasculature was unaffected in aplnra morpholino-injected embryos, these embryos did contain profound defects in lymphatic vessels ( Figure 1B and 1C). To visualize developing LECs, we used Tg(fli1a:nEGFP);Tg(kd rl:mCherry) double transgenic lines, which contain nEGFP + / mCherry + BECs (appearing as yellow in the merged figures) and nEGFP + /mCherry − LECs. Although the developing thoracic duct, located between the dorsal aorta and the cardinal vein, was clearly visible in 4 dpf control morpholino-injected embryos, similar structures were absent in aplnra morpholino-injected embryos ( Figure 1B ). In addition, the number of nEGFP + /mCherry − LECs within the thoracic duct in aplnra morpholino-injected embryos was greatly decreased ( Figure 1C ), suggesting that LECs are more sensitive to attenuated level of Apelin/Aplnr signaling activity. Similarly, the number of VEGFR3 + LECs in the diaphragm of Apj −/− mice was significantly reduced ( Figure IE and IF in the online-only Data Supplement), suggesting that the role of Apelin/Aplnr signaling on lymphatic development may be conserved within vertebrate species.
We next determined whether the attenuation of the cognate ligand of Aplnr, Apelin, would cause comparable defects in lymphatic development. To ensure that the lymphatic defects found in apln morpholino-injected embryos are not secondary to the previously reported cardiac defects, 17, 19 the amount of morpholino was titrated. Injection of 2.7 or 5.4 ng per embryo effectively blocked the normal splicing of apln transcript ( Figure (Figure 2A and 2B). At 3 dpf, embryos injected with 2.7 ng of apln morpholino completely lacked parachordal vessel. Consistent with the defects in parachordal vessels, we found that the number of LECs in 4 dpf apln morpholinoinjected embryos was decreased in a dose-dependent manner ( Figure 2C and 2D). Consistent with these findings, microlymphangiography demonstrated that embryos with a reduced level of Apelin signaling do not develop proper lymphatic vessels ( Figure III in the online-only Data Supplement). Because LECs emerge from venous ISVs, 12 it is possible that a decrease in Apelin signaling activity may limit the number of forming venous ISVs and indirectly influence the number of LECs. To evaluate this possibility, we examined the effects of Apelin signaling on the formation of venous ISVs by counting the number of ISVs that were directly connected to the cardinal vein (venous ISV connections) at 4 dpf. Although the number of LECs was substantially decreased by injecting a low concentration of apln morpholino (0.9 and 1.8 ng/embryo), the number of venous ISV connections was largely unaffected ( Figure 2E and 2F), suggesting that Apelin signaling is likely to directly regulate lymphatic development in zebrafish embryos.
To further confirm that the lymphatic defects in apln morpholino-injected embryos are directly caused by the attenuation of Apelin signaling, we attempted a phenotypic rescue of apln morpholino-injected embryos by injecting synthetic apln mRNA. Because apln mRNA injection can cause cardiac defects, 17 the amount of mRNA was titrated. Although a high dose of apln mRNA caused severe cardiac defects, injection of 8 pg apln mRNA per embryo did not cause any phenotypic defects ( Figure IVA and IVB in the online-only Data Supplement). When coinjected, 8 pg apln mRNA successfully restored the number of LECs in apln morpholino-injected embryos ( Figure 2G and 2H), suggesting that the reduction in the number of LECs in apln morpholinoinjected embryos was not a secondary effect of general developmental delays caused by morpholino injection. Taken together, our data suggest that proper activity of Apelin/Aplnra signaling is essential for lymphatic development in zebrafish embryos.
Apelin Signaling Modulates AKT Activity in Human and Zebrafish LECs
It has been reported that Apelin promotes the migration of BECs and LECs in cell culture. 25 Consistent with the previous report, knockdown of APLNR in human LECs (hLECs) adversely affected the migration of hLECs. In a scratch wound assay, APLNR small interfering RNA (siRNA)-treated hLECs displayed a significantly attenuated migratory behavior compared with control siRNA-treated hLECs ( Figure 3A and 3B) . The migration defect of APLNR siRNA-treated hLECs was likely caused by a reduced level of Apelin signaling because addition of exogenous Apelin 13 was not able to alleviate the migration defects in APLNR siRNA-treated hLECs ( Figure 3A and 3B) .
To identify the downstream effectors of Apelin signaling in LECs, we examined the level of phospho-AKT1/2 and phospho-extracellular signal-regulated kinase 1/2 (ERK1/2) in APLNR siRNA-treated hLECs ( Figure 3C ). Because it has been reported that ERK1/2 and AKT, which function as downstream effectors for several G protein-coupled receptors including APLNR, 16, 27, 28 are essential for modulating the development of lymphatic vessels, 1,3 it is tempting to speculate that ERK1/2 and AKT may be involved in downstream of Apelin signaling during lymphatic development. Although the level of phospho-ERK1/2 did not change in APLNR siRNA-treated hLECs compared with control siRNA-treated cells, the level of phospho-AKT1/2 was significantly decreased on APLNR depravation ( Figure 3C-3E) . Moreover, stimulation with Apelin ligand in hLECs led to an increased level of phospho-AKT1/2 in a dose-dependent manner ( Figure V in the online-only Data Supplement). Similarly, attenuation of Apelin signaling by morpholino injection drastically reduced the level of phospho-AKT1/2 in developing zebrafish. Although phospho-AKT1/2 is strongly detected within ECs in the dorsal aorta and cardinal vein of 48-hour postfertilization control morpholino-injected embryos, it is largely absent in apln morpholino-injected embryos ( Figure 3F ). Therefore, it seems that Apelin signaling may function as a major stimulus for AKT1/2 phosphorylation in both cell culture and in vivo. Previously, Aplnrs have been reported to function independent of Apelin ligand. 18 Therefore, we also examined the level of phospho-AKT1/2 in apln morpholino-injected embryos and found that phospho-AKT1/2 was substantially reduced in these embryos, suggesting that phosphorylation of AKT1/2 is dependent on Apelin/Aplnr signaling ( Figure 3F ).
Apelin and AKT Activity Functionally Cooperate for Zebrafish Lymphatic Vessel Formation
To further substantiate the link between AKT activity and Apelin signaling in LECs, we manipulated the level of AKT activity in zebrafish embryos and examined the effects on developing LECs. Because manipulation of AKT activity at earlier developmental stages may compromise the specification of arterial and venous ECs, [29] [30] [31] we used previously reported chemical antagonists of AKT to induce temporal AKT inhibition. Treatment with either 10 μmol/L LY294002 (phosphoinositide 3-kinase inhibitor) 32 or 2 μmol/L Torin1 (mammalian target of rapamycin complex 1 and 2 inhibitor), 33 both of which inhibit AKT phosphorylation, drastically reduced the number of LECs in 4 dpf zebrafish embryos ( Figure 4A-4D) . Moreover, the lymphatic defects caused by a partial reduction of Apelin signaling activity were significantly exacerbated by administering a suboptimal dose of the aforementioned chemical antagonists of AKT ( Figure 4E-4G) . Although embryos injected with 0.9 ng of apln morpholino or treated with 5 μmol/L of LY294002 contained an average of 5.6±0.65 and 6.2±0.79 LECs, respectively, embryos that were injected with 0.9 ng of apln morpholino and treated with 5 μmol/L of LY294002 had significantly fewer LECs (3.8±1.11), representing a further ≈40% reduction the in number of LECs compared with single manipulations (Figure 4E and 4F). Similar effects were also observed in embryos that were injected with 0.9 ng of apln morpholino and treated with 1 μmol/L of Torin1 (≈40% reduction; Figure 4E and 4G).
Apelin and VEGF-C Signal Independently in Zebrafish Lymphatic Development
Previously, it has been reported that AKT activity within ECs can be induced by VEGF-C signaling, [34] [35] [36] which is the key stimulus for lymphatic development. 37, 38 We next tested whether Apelin and VEGF-C signaling converge at the level of AKT or function redundantly to promote differentiation and maintenance of LECs. Attenuation of Apelin signaling did not influence the expression of VEGF-C signaling components, including expression of vegfc or its receptor flt4 ( Figure  VIA in the online-only Data Supplement). Similarly, inhibition of VEGF-C signaling activity did not affect the expression of apln, aplnra, or aplnrb ( Figure VIB in the online-only Data Supplement). However, coinjection of apln and vegfc morpholino with suboptimal doses exacerbated the lymphatic phenotypes ( Figure 5A and 5B) , indicating that Apelin and VEGF-C signaling may synergistically promote lymphatic development. We next examined whether Apelin signaling is sufficient to compensate for the loss of VEGF-C signaling. Ectopic activation of Apelin signaling by synthetic mRNA injection was unable to alleviate the lymphatic defects in vegfc morpholino-injected embryos ( Figure 5C and 5D) . In a similar manner, ectopic expression of Vegfc by synthetic mRNA injection was unable to restore the lymphatic abnormalities caused by reduced Apelin signaling ( Figure 5E and 5F). The inability of apln mRNA to alleviate the defects of vegfc morpholino-injected embryos and vegfc mRNA to apln morpholino-injected embryos collectively suggest that Apelin and Vegfc signaling may function in a nonredundant manner in lymphatic development.
Considering that both Apelin and Vegfc signaling can activate AKT to induce lymphatic development, but seem to have nonredundant functions, it is possible that Vegfc and Apelin signaling may have distinct functions; although Vegfc may potentiate presumptive LECs within venous vascular beds, Apelin signaling may successively promote differentiation of LECs in later developmental stages. Alternatively, it is possible that Apelin and Vegfc signaling may induce AKT activity in a temporally distinct manner. To examine this possibility, we analyzed the expression of apln, aplnra, vegfc, and vegfr3 within the first 5 days of development in zebrafish embryos ( Figure 6A) . Although the expression level of vegfc gradually increased and then stabilized, the expression level of vegfr3 precipitously dropped by 2 dpf, indicating that the activity of Vegfc-Vegfr3 signaling may reduce to the basal level when LECs emerge from venous ISVs ( Figure 6A ). In contrast, the expression of apln and aplnra continuously increased during the first 5 days of development ( Figure 6A and Figure VIC in the online-only Data Supplement), suggesting functions of Apelin signaling may be required later in development than Vegfc signaling.
Discussion
Considering the expression pattern of Apelin signaling components during development, and their role during lymphatic regeneration, 16, 25, 26 it is likely that Apelin signaling provides key regulation during lymphatic development. In this report, we have demonstrated that Apelin signaling-induced AKT activity is essential for differentiation of LECs during development. AKT activity has been implicated in both developmental and pathological lymphangiogenesis. 34, 37, 38 For instance, targeted deletion of Akt1, Akt2, or Akt3 in mouse caused a significant reduction in the number of developing LECs and led to defects in lymphatic valve formation. 37, 39 In addition, Kaposi's sarcoma associated herpesvirus activates AKT to induce ectopic lymphatic structures. 40, 41 Although AKT can be activated by diverse signaling inputs, 42, 43 attenuating Apelin signaling substantially decreased the phosphorylation of AKT in LECs, both in cell culture and developing zebrafish embryos. Therefore, it seems that Apelin signaling may function as a main inducer of AKT activity within LECs. Moreover, our data suggest that Apelin signaling may coordinate with VEGF-C signaling, an essential prolymphangiogenic signaling pathway, 34, 36, 39 to maintain the proper level of AKT activity in LECs. During development, components of Apelin and Vegfc signaling seem to be expressed at distinct stages, suggesting that these 2 prolymphangiogenic signaling pathways may activate the same downstream effectors, but their activity may be temporally separated during development ( Figure 6B) .
Although Apelin signaling is required for AKT activation in LECs and the disruption of the Apelin-AKT signaling cascade drastically reduced the number of LECs in zebrafish, ectopic AKT activation by chemical agonists (data not shown), and ectopic expression on Vegfc ( Figure 5E ) were not sufficient to restore the number of LECs in zebrafish embryos with compromised Apelin signaling. Therefore, it is likely that the prolymphangiogenic role of Apelin signaling may be transduced by additional effectors. ERK1/2, which are known to be activated by Vegfc signaling in LECs, 35, 36 do not seem to mediate Apelin signaling in LECs because lack of Apelin signaling did not affect the phosphorylation status of ERK1/2 in hLECs ( Figure 3C ). Ongoing work in the laboratory is examining the role of other serine-threonine kinases, including ERK5, Raf, and protein kinase A, as potential downstream mediators of Apelin signaling in LECs. Convergence of Apelin and VEGF-C at AKT, as well as divergent signaling pathways activated by these distinct signaling cascades, likely provide the necessary cues that ensure proper lymphatic development. Figure 6 . Apelin and vascular endothelial growth factor-C (Vegfc) signaling is temporally separated for lymphatic vessel formation in zebrafish. A, Expression profiles of apln, aplnra, vegfc, and vegfr3 during the first 5 days of zebrafish development, normalized to actb1. The expression of apln and aplnra gradually increased over time, whereas the expression of vegfc and vegfr3 is either constant or attenuated. B, Schematic working model. Apelin and Vegfc signaling seem to have nonoverlapping functions during lymphatic development. Although functionally redundant in activating serine-threonine kinase Akt/protein kinase B (AKT), Apelin and Vegfc signaling may be temporally separated and seem to activate specific sets of downstream effectors. dpf indicates days postfertilization; and ERK1/2, extracellular signal-regulated kinase 1/2.
